A newly characterized malaria antigen on erythrocyte and merozoite surfaces induces parasite inhibitory antibodies
Authors:
- Ian C. MichelowIMIan C. Michelow
- Sangshin ParkSPSangshin Park
- Shu-Whei TsaiSTShu-Whei Tsai
- Bonnie RaytaBRBonnie Rayta
- Charisse Flerida A. PasajeCharisse Flerida A. Pasaje
- Sara NelsonSNSara Nelson
- Angela M. EarlyAEAngela M. Early
- Anne P. FroschAFAnne P. Frosch
- George AyodoGAGeorge Ayodo
- Dipak K. RajDRDipak K. Raj
- Christina E. NixonCNChristina E. Nixon
- Christian P. NixonCNChristian P. Nixon
Open Access
- 3 August 2021
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (9)
Abstract
We previously identified a Plasmodium falciparum (Pf) protein of unknown function encoded by a single-copy gene, PF3D7_1134300, as a target of antibodies in plasma of Tanzanian children in a whole-proteome differential screen. Here we characterize this protein as a blood-stage antigen that localizes to the surface membranes of both parasitized erythrocytes and merozoites, hence its designation as Pf erythrocyte membrane and merozoite antigen 1 (PfEMMA1). Mouse anti-PfEMMA1 antisera and affinity-purified human anti-PfEMMA1 antibodies inhibited growth of P. falciparum strains by up to 68% in growth inhibition assays. Following challenge with uniformly fatal Plasmodium berghei (Pb) ANKA, up to 40% of mice immunized with recombinant PbEMMA1 self-cured, and median survival of lethally infected mice was up to 2.6-fold longer than controls (21 vs. 8 d, P = 0.005). Furthermore, high levels of naturally acquired human anti-PfEMMA1 antibodies were associated with a 46% decrease in parasitemia over 2.5 yr of follow-up of Tanzanian children. Together, these findings suggest that antibodies to PfEMMA1 mediate protection against malaria.Keywords
Funding Information
- National Institute of General Medical Sciences
- National Institutes of Health (P20GM104317)
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (R01AI142743-010, R01 AI136511)
- Bill and Melinda Gates Foundation (OPP1158199)
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (K08AI100997, R25AI140490)
- Lifespan Inc.
- Rhode Island Foundation
- National Science Foundation
- U.S. Department of Energy
- Established Program to Stimulate Competitive Research (EPS-1004057)
This publication has 70 references indexed in Scilit:
- Scalable web services for the PSIPRED Protein Analysis WorkbenchNucleic Acids Research, 2013
- The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessmentScientific Reports, 2013
- Quantitative assessment ofPlasmodium falciparumsexual development reveals potent transmission-blocking activity by methylene blueProceedings of the National Academy of Sciences, 2011
- The Phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii Reveal Unusual Adaptations Within and Beyond the Parasites' BoundariesCell Host & Microbe, 2011
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibodyNature Communications, 2011
- Dual stage synthesis and crucial role of cytoadherence-linked asexual gene 9 in the surface expression of malaria parasite var proteinsProceedings of the National Academy of Sciences, 2010
- New insights into the blood‐stage transcriptome of Plasmodium falciparum using RNA‐SeqMolecular Microbiology, 2010
- PlasmoDB: a functional genomic database for malaria parasitesNucleic Acids Research, 2008
- Selective permeabilization of the host cell membrane of Plasmodium falciparum-infected red blood cells with streptolysin O and equinatoxin IIBiochemical Journal, 2007
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986